PEPTONIC medical in pre-IND meeting at FDA
PEPTONIC medical today announced that it met with the US Food and Drug Administration (FDA) earlier this month in a so called pre-IND meeting. The objectives of the meeting were to obtain FDA’s view on the clinical documentation generated to date and to seek advice regarding the continued clinical development of VAGITOCIN® towards a marketing […]
